Glanbia plc Half Year 2020 Results presentation Group Managing - - PowerPoint PPT Presentation

glanbia plc
SMART_READER_LITE
LIVE PREVIEW

Glanbia plc Half Year 2020 Results presentation Group Managing - - PowerPoint PPT Presentation

Glanbia plc Half Year 2020 Results presentation Group Managing Director Group Finance Director 2 Glanbia plc | Half Year 2020 presentation Important notice This presentation contains forward-looking statements. These statements have been


slide-1
SLIDE 1

Glanbia plc Half Year 2020 Results presentation

Group Managing Director Group Finance Director

slide-2
SLIDE 2

This presentation contains forward-looking statements. These statements have been made by the Directors in good faith based on the information available to them up to the time of their approval of this presentation. Due to the inherent uncertainties, including both economic and business risk factors underlying such forward-looking information, actual results may differ materially from those expressed or implied by these forward- looking statements. The Directors undertake no obligation to update any forward-looking statements contained in this presentation, whether as a result of new information, future events, or otherwise.

Important notice

Glanbia plc | Half Year 2020 presentation 2
slide-3
SLIDE 3

Strong position from outset of the crisis

Glanbia plc | Half Year 2020 presentation 3

Covid-19 – Delivering against our priorities

Protecting

  • ur people

Maintaining food supply Maintain financial position

Managed health and safety

  • f employees rigorously

Maintained production across the Group throughout the crisis Net debt: Adjusted EBITDA 1.95x

slide-4
SLIDE 4

Evolving market dynamics

Glanbia plc | Half Year 2020 presentation 4

Customers Consumers Our Communities

  • Increased focus on health and

wellness brands and ingredients

  • Consumers loyal to established

brands in performance nutrition and weight management

  • Disproportionate impact to certain

demographics

  • Acceleration in growth in

ecommerce and decline of specialty channels in GPN

  • Retailers simplifying

assortment and shelf space

  • Strong demand for functional

ingredients

  • Our values came to life with

multiple examples of community support across the Group

  • Business sustainability and the

health and wellbeing of employees paramount

  • Strong liquidity and cash

management meant no drawdowns of Governmental supports

Portfolio well positioned

slide-5
SLIDE 5
  • 50%
  • 30%
  • 10%
10%

Q1 Apr May Jun Jul

GPN YoY revenue progression 2020

Implications for Glanbia in H1 2020

Glanbia plc | Half Year 2020 presentation 5

Joint Ventures –

  • verall staple food

demand good

Sports & Lifestyle Nutrition Supplements/ Immunity Fortified Food & Beverage Specialised Nutrition US Cheese

Significant volatility in Q2 International & North America Specialty channel primary drivers of decline Improving trends into H2 New JV projects

  • n track

Trends improving Resilient through Covid-19

slide-6
SLIDE 6 Glanbia plc | Half Year 2020 presentation 6

Our strategy is aligned to the new environment

Glanbia Performance Nutrition Glanbia Nutritionals Group

  • Streamline products, prioritise

ON and SlimFast brands

  • Reorganise and optimise

route-to-market & supply chain

  • Grow solutions capability across

key platforms

  • Expand into complementary

adjacencies - Foodarom acquisition

  • Maintain prudent capital

deployment policy

  • Continue JV developments
  • Lean into Glanbia purpose

to navigate crisis

  • Evolve longer term ways of

working to new environment

  • Maintain customer relationships with

new forms of engagement

  • Support immediate customer needs

for health & wellness products

  • Further recalibration of

International business

  • Deepen NA review across

demand & productivity

Existing strategy

  • n track

Covid-19 response

slide-7
SLIDE 7

Glanbia structured well to capture opportunities

Glanbia plc | Half Year 2020 presentation 7

Trends driving our business have grown more powerful

Health and wellness Digital Our Categories

Brand in performance nutrition & Brand in weight management in the US ON & SlimFast

  • f GPN sales
  • f GPN sales now
  • nline

Producer of protein solutions for convenient nutrition category in US Essential micro nutrients ingredients supplier Globally Protein category resilient Weight management in growth Immune enhancing ingredients and brands very ‘on-trend’ Reduced ‘food-to-go’ demand Food staples demand strong

Now in markets + hosting ON DTC websites

slide-8
SLIDE 8

Glanbia Performance Nutrition HY20 review

slide-9
SLIDE 9

€620.1m 1.7% (14.9%) (0.7%) €532.4m

HY19 FX Volume Price HY20

Revenue progression

North America Performance Nutrition

  • Strong underlying branded performance in online and FDMC

channels offset by weak specialty and distributor channels in Q2

North America Lifestyle

  • Pantry loading at the outset of Q2 stabilised by the end of the
  • period. RTE* category weak but improving as the period progressed
  • Delivered volume growth overall in H1 due to a strong performance

from SlimFast and Amazing Grass

International

  • Severe disruption to demand as a result of lockdowns
  • As lockdowns eased at the end of Q2 markets began to reopen

DTC

  • Positive volume performance and expansion in H1 with dedicated

teams now servicing 10 markets

EBITA

  • International market disruption created negative operating leverage
  • Underlying margins in line with PY pre-Covid-19 impact

GPN Half Year review

Glanbia plc | Half Year 2020 presentation 9
  • 59.1% cc

€19.6m

EBITA

  • 390 bps

3.7%

MARGIN

*RTE – ready-to-eat

Improving trends and margins into Q3

slide-10
SLIDE 10

GPN transformation focused on revenue and margin growth

Glanbia plc | Half Year 2020 presentation 10

International route-to-market Revenue growth management Channel focus Brand focus Supply chain Productivity Global footprint SKUs and contract exit

Demand Efficiency

Portfolio streamlined – 35% of SKUs removed and ON & SlimFast now 69% of sales GPN reorganised into 4 focus areas New RTM partners in place in International markets NA Contract exit on track Scope increased as a result

  • f Covid-19
  • Recalibration of International
  • Deepen review in NA across

demand & productivity leveraging FDMC & online acceleration

Supply chain consolidation underway

Targeting EBITA margins of 12% to 13% by 2022

slide-11
SLIDE 11

Significant position in growth channels – online and FDMC

Glanbia plc | Half Year 2020 presentation 11

Revenue by channel

FDMC 34% Online 26% Distributors 20% Specialty 20% FDMC 40% Online 34% Distributors 12% Specialty 14%

Channel HY 20 Growth* FDMC +1% Online +11% Distributors (46%) Specialty (41%)

*Reported currency

slide-12
SLIDE 12

North America Performance Nutrition 38% North America Lifestyle 29% International 27% DTC 6% North America Performance Nutrition 37% North America Lifestyle 35% International 21% DTC 7%

GPN has a scale business in North America

Glanbia plc | Half Year 2020 presentation 12

Market HY 20 Growth NA PN* (11%) NA Lifestyle +2% International (33%) DTC (5%)

*LFL Branded

Revenue by market

slide-13
SLIDE 13
  • LFL Branded revenue declined by 11.4% in H1

due to challenging Q2

  • ON measured consumption -4% in H1 with the

trend sequentially improving during Q2

  • Headwinds in H1 primarily due to challenges

in the specialty and distributor channels which impacted branded and contract sales

  • Majority of this business now oriented around
  • nline and club channels with growing presence

in FDM and consumption trends improved at the end of Q2

  • ON has a stronger competitive position in online

and club versus specialty

North America Performance Nutrition

Glanbia plc | Half Year 2020 presentation 13

ON net promoter score increased and is the highest in the category

slide-14
SLIDE 14
  • Revenue grew 2% in H1
  • SlimFast consumption growth of 13.0% in H1
  • Majority of this business in FDM channels with a

growing presence online

  • Volatility in sales as a result of pantry loading in Q2

which stabilised by the end of the period

  • Headwinds in RTE category expected to remain as

long as mobility in NA remains below normal levels

  • Strong alignment with consumer needs around weight

management (SlimFast) as well as natural immunity (Amazing Grass)

North America Lifestyle

Glanbia plc | Half Year 2020 presentation 14

Brand awareness Household penetration up 60 bps to 5.0%

98%

slide-15
SLIDE 15
  • Revenue declined 33% in H1
  • Route-to-market disrupted in many territories:
  • Lockdowns shut down operations in some countries entirely
  • Footfall in high street specialty stores down significantly
  • Gym closures impacted demand
  • Sales very volatile leading to significant negative operating

leverage in H1

  • Conditions improved in June/July as lockdowns eased
  • Remain optimistic on selective growth opportunities
  • Key route-to-market changes outlined in February now

complete with clear brand focus, new team and new in-market partners in certain regions

  • Covid-19 has further informed the business review;

aim is to right size the organisation to the opportunity, scaling back footprint in certain markets while leveraging ecommerce capability across all markets

International

Glanbia plc | Half Year 2020 presentation 15
slide-16
SLIDE 16
  • DTC revenue declined 5%

in H1

  • Revenue trajectory improving
  • H1 declines in key Benelux

market as a result of gym closures

  • Dedicated teams covering 10

markets in Europe and RoW

  • DTC team commencing

management of ON brand DTC website

DTC – eCommerce opportunity

Glanbia plc | Half Year 2020 presentation 16

DTC Brand.com

Russia Sweden Portugal Italy France Spain UK Germany Poland Benelux

Existing markets New markets entered in 2020

slide-17
SLIDE 17

Glanbia Nutritionals HY20 review

slide-18
SLIDE 18

Glanbia Nutritionals Half Year review

Glanbia plc | Half Year 2020 presentation 18

+12.0% cc

€1,304.3m

REVENUE

  • 0.9% cc

€65.4m

EBITA

  • 70 bps

5.0%

MARGIN

Resilient performance in H1

slide-19
SLIDE 19

€369.6m 2.0% 1.2% (1.8%) 3.5% €387.9m

HY19 FX Volume Price Acquisition HY20

Revenue progression Non-dairy Ingredients

  • Strong underlying demand for essential micro nutrients
  • Some volume headwinds in ‘food-to-go’ category due to

Covid-19

Dairy Ingredients

  • Good demand for specialist dairy ingredient solutions
  • Negative pricing due to pass through of commodity prices

Watson

  • Solid performance from Watson which was acquired in

February 2019

  • Integration on track

EBITA

  • Some headwinds due to lower ‘food-to-go’ customer

demand

  • Margins robust at 12.4%; H1 decline due to adverse

product mix

Nutritional Solutions Half Year review

Glanbia plc | Half Year 2020 presentation 19
  • 6.8% cc

€48.1m

EBITA

  • 130 bps

12.4%

MARGIN

slide-20
SLIDE 20

Essential Micro Nutrients

  • Powerful trends driving end market growth
  • Core solutions are essential micro nutrients

and value-added protein ingredients

  • Market leading positions in core solutions
  • Customers range from global to regional

brand owners in categories across mainstream food & beverage and specialised nutrition and supplements

  • Scaling capabilities through acquisition

Nutritional Solutions Strategy

Glanbia plc | Half Year 2020 presentation 20

Core Solutions Providing the building blocks for our customers’ brands in the following categories

Supplements Clinical Nutrition Early Life Nutrition Performance Nutrition Lifestyle Nutrition

Protein Ingredients

slide-21
SLIDE 21

Glanbia has agreed to acquire ‘Foodarom’, a c.CAD 34m revenue flavors business based in Montreal, Canada

Foodarom acquisition announcement

Glanbia plc | Half Year 2020 presentation 21

Foodarom has a strong flavor formulation capabilityand is focused

  • n segments complementary to NS

Foodarom has manufacturing and applications facilities in Canada, the US and Europe Foodarom is scalable and will enable the further development of flavor solutions within NS Expected to complete in H2 2020 subject to the customary closing conditions and be earnings accretive from 2021 Purchase price is CAD 60m plus contingent consideration

Description Strategic rationale Transaction details

slide-22
SLIDE 22

€768.7m 2.5% 6.0% 10.3% €916.4m

HY19 FX Volume Price HY20

Revenue progression

US Cheese Half Year review

Glanbia plc | Half Year 2020 presentation 22

+20.1% cc

€17.3m

EBITA +10 bps

1.9%

MARGIN

Volumes

  • Strong volume performance driven by

customers with retail end markets

Pricing

  • Pricing volatile in Q2; pass through model
  • perated with suppliers

Operations

  • Strong operating performance across all

plants which improved margin

EBITA

  • EBITA driven by revenue growth
slide-23
SLIDE 23 * Includes Glanbia’s share of revenue from the Glanbia Ireland and Glanbia Cheese UK Joint Ventures ** Includes Glanbia’s share of profits from the Glanbia Ireland, Glanbia Cheese UK and Southwest Cheese Joint Ventures

Joint Ventures Half Year review

Glanbia plc | Half Year 2020 presentation 23
  • 1.4% cc

€453.6m

Revenue*

+17.3% cc

€31.8m

Share of PAT**

JV business model

  • JV business models performed robustly in period of

unprecedented volatility

Revenue

  • Decline driven by negative market pricing in Europe

Profitability

  • All JVs delivered improved profitability

New JV projects

  • Scale projects in Ireland and USA on track
slide-24
SLIDE 24

Half Year 2020 Finance review

Mark Garvey

Group Finance Director

slide-25
SLIDE 25

Net debt to adjusted EBITDA 1.95 times Wholly-owned Revenue growth of 2.3%, constant currency Adjusted EPS down 17.2% constant currency due to Covid- 19 related disruption Strong performance by Glanbia Nutritionals offset by Q2 weakness in GPN Interim dividend payment of 10.68c cent GN & JVs continue to be resilient Good operating cash flow performance GPN improving after challenging Q2 with strategic initiatives

  • n track

HY 2020 – Resilient performance in a challenging environment

Glanbia plc | Half Year 2020 presentation 25

Growth Earnings Cash & Debt Dividends Current trading

GPN International disruption primary impact on earnings Dividend payout ratio 34%

slide-26
SLIDE 26

HY 2020 results summary pre-exceptional €'m Reported currency Constant currency

HY 2020 HY 2019 Change Change Revenue (Wholly-owned) 1,836.7 1,758.4 4.5% 2.3% EBITA (Wholly-owned) 85.0 111.4 (23.7%) (25.4%) EBITA margin 4.6% 6.3%

  • 170 bps
  • 170 bps

Amortisation (30.5) (28.9) Net Finance Costs (11.5) (13.3) Share of Joint Ventures 31.8 26.8 Income Tax (4.9) (9.2) Profit for the period (pre-exceptional) 69.9 86.8 Adjusted EPS 31.05c 36.69c (15.4%) (17.2%) Basic EPS 18.73c 28.22c

Half Year Group Income Statement

Glanbia plc | Half Year 2020 presentation 26
  • Revenue growth driven by GN
  • EBITA decline driven by GPN

International

  • EBITA margins impacted mainly

by negative operating leverage in GPN due to Covid-19 impact

  • Good performance from JVs
slide-27
SLIDE 27
  • Reorganisation costs primarily relates to GPN transformation underpinning the margin growth ambition
  • Covid-19 costs associated with increased payments to front line workers during the height of the pandemic

and other incidental costs

Exceptional Items HY 2020 HY 2019

€‘m €‘m Reorganisation costs 15.2 3.2 Covid-19 costs 3.5

  • Legal settlement gain

(3.5)

  • Brexit related costs
  • 1.1

Exceptional charge before tax 15.2 4.3 Share of results of Joint Venture – Covid-19 costs 1.2

  • Exceptional tax credit

(1.8) (0.8) Total exceptional charge after tax 14.6 3.5

Exceptional Items

Glanbia plc | Half Year 2020 presentation 27
slide-28
SLIDE 28 Glanbia plc | Half Year 2020 presentation 28

Strong Cash Flow enabling investment & returns

€47m

OCF improved by €28 million Operated to plan across the Group throughout the crisis FY20 capex expected to be in the €65m to €75m range

€18m

Total capex

€29m

10.68c

Operating Cash Flow Dividends from JVs Capital Expenditure Interim Dividend Targeting +80% OCF conversion for FY20 Dividend payout 34%

slide-29
SLIDE 29

Improving Balance Sheet

Glanbia plc | Half Year 2020 presentation 29
  • Strong Balance Sheet to navigate

the Covid-19 pandemic

  • Net debt decreased by €127m
  • n prior half year mainly due

to strong cash generation

  • New 11 year $175 million facility to

be drawn down in December 2020

  • Post-HY20 acquisition of

Foodarom for CAD 60m

  • Total committed facilities exceed

€1.1 billion

Balance Sheet KPIs HY 2020 HY 2019

Net Debt €651m €778m

Net Debt / Adj. EBITDA 1.95x 2.14x

  • Adj. EBIT / Net Financing Costs

9.4x 10.5x

slide-30
SLIDE 30

Conclusion

Siobhán Talbot

Group Managing Director

slide-31
SLIDE 31

Conclusions

Glanbia plc | Half Year 2020 presentation 31
  • Well positioned portfolio to capitalise on consumer trends
  • Delivering against our priorities during Covid-19
  • Trends improving into Q3 following a challenging Q2
  • Strong financial position maintained
  • Strategy on track with focus on GPN transformation
slide-32
SLIDE 32

Questions

slide-33
SLIDE 33

APPENDIX

slide-34
SLIDE 34

Non-IFRS performance measure definitions

Glanbia plc | Half Year 2020 presentation 34

The Group reports certain performance measures that are not defined under IFRS but which represent additional measures used by the Board of Directors and the Glanbia Operating Executive in assessing performance and for reporting both internally and to shareholders and other external users. The Group believes that the presentation of these non-IFRS performance measures provides useful supplemental information which, when viewed in conjunction with our IFRS financial information, provides readers with a more meaningful understanding of the underlying financial and operating performance of the Group.

  • 1. While the Group reports its results in euro, it generates a significant proportion of its earnings in currencies other than euro, in particular US dollar. Constant currency reporting is used by the Group to eliminate the translational

effect of foreign exchange on the Group's results. To arrive at the constant currency period-on-period change, the results for the prior year are retranslated using the average exchange rates for the current year and compared to the current period reported numbers

  • 2. The Group has a number of strategically important Equity accounted investees (Joint Ventures) which when combined with theGroup’s wholly-owned businesses give an important indication of the scale and reach of the

Group’s operations. Total Group is used to describe certain financial metrics such as Revenue and EBITA when they include both the wholly-owned businesses and the Group's share of equity accounted investees

  • 3. Revenue comprises sales of goods and services of the wholly-owned businesses to external customers net of value added tax, rebates and discounts
  • 4. EBITA is defined as earnings before interest, tax and amortization. EBITA references throughout the half year results are on a pre-exceptional basis unless otherwise indicated
  • 5. EBITA margin is defined as EBITA as a percentage of revenue
  • 6. EBITDA is defined as earnings before interest, tax, depreciation (net of grant amortisation) and amortization. EBITDA references throughout the half year results are on a pre-exceptional basis unless otherwise indicated
  • 7. Basic Earnings Per Share is calculated by dividing the net profit attributable to the equity holders of the Company by the weighted average number of ordinary shares in issue during the period, excluding ordinary shares

purchased by the Group and held as own shares

  • 8. Adjusted EPS is defined as the net profit attributable to the equity holders of Glanbia plc, before exceptional items and intangible asset amortisationand impairment (excluding software amortisation), net of related tax, divided by

the weighted average number of ordinary shares in issue during the period. The Group believes that adjusted EPS is a better measure of underlying performance than Basic EPS as it excludes exceptional items (net of related tax) that are not related to ongoing operational performance and intangible asset amortisation, which allows better comparability of companies that grow by acquisition to those that grow organically

  • 9. Net debt: adjusted EBITDA is calculated as net debt at the end of the period divided by adjusted EBITDA. Net debt is calculated as total financial liabilities less cash and cash equivalents. Adjusted EBITDA is calculated in

accordance with lenders’ facility agreements definition which adjust pre-exceptional EBITDA for items such as dividends received from Equity accounted investees, acquisitions or disposals and to reverse the net impact on EBITDA as a result of adopting IFRS 16 ‘Leases’. Adjusted EBITDA is a rolling 12 month measure, therefore for half year 2020 and half year 2019 it is calculated as the Adjusted EBITDA for the preceding 12 months ending on the relevant reporting dates

  • 10. Adjusted EBIT: net finance cost is calculated as earnings before interest and tax adjusted for the IFRS 16 ‘Leases’ impact on operating profit plus dividends received from Equity accounted investees divided by net finance cost.

Net finance cost comprises finance costs less finance income per the Condensed Group income statement plus capitalised borrowing costs and excludes Interest expense on lease liabilities. Adjusted EBIT and net finance cost are rolling 12 month measures, therefore for half year 2020 and half year 2019 are calculated as the Adjusted EBIT and net finance costs for the preceding 12 months

slide-35
SLIDE 35

Non-IFRS performance measure definitions

Glanbia plc | Half Year 2020 presentation 35
  • 11. The Group considers that items of income or expense which are material by virtue of their scale and nature should be disclosed separately if the Group financial statements are to fairly present the financial performance and

financial position of the Group. Determining which transactions are to be considered exceptional in nature is often a subjectivematter. However, circumstances that the Group believes would give rise to exceptional items for separate disclosure are outlined in the accounting policy on exceptional items in note 2 to the financial statement in the 2019 financial statements

  • 12. Volume increase/(decrease) represents the impact of sales volumes within the revenue movement period-on-period, excluding volume from acquisitions, on a constant currency basis. Pricing increase/(decrease) represents the

impact of sales pricing (including trade spend) within revenue movement period-on-period, excluding acquisitions, on a constant currency basis

  • 13. Glanbia Performance Nutrition like-for-like branded revenue represents the sales increase/(decrease) period-on-period on branded sales, excluding acquisitions, on a constant currency basis
  • 14. Glanbia Nutritionals like-for-like revenue represents the sales increase/(decrease) period-on-period, excluding acquisitions, on a constant currency basis
  • 15. The effective tax rate is defined as the pre-exceptional income tax charge divided by the profit before tax less share of results of equity accounted investees
  • 16. The average interest rate is defined as the annualised net finance costs (pre-capitalised borrowing costs and excluding interest expense on lease liabilities) divided by the average net debt during the reporting period
  • 17. The Group defines strategic capital expenditure as the expenditure required to facilitate growth and generate additional returns for the Group. This is generally expansionary expenditure beyond what is necessary to maintain the

Group’s current competitive position.

  • 18. Operating cash flow is defined as pre-exceptional EBITDA of the wholly-owned businesses net of business sustaining capital expenditure and working capital movements, excluding exceptional cash flows. Free cash flow is

calculated as the net cash flow in the period before the following items: strategic capital expenditure, proceeds received ondisposals, loans to / investments in equity accounted investees, equity dividends paid, exceptional costs paid, acquisition spend and currency translation movements

  • 19. The Group defines business-sustaining capital expenditure as the expenditure required to maintain/replace existing assets with a high proportion of expired useful life. This expenditure does not attract new customers or create the

capacity for a bigger business. It enables the Group to keep running at current throughput rates but also keep pace with regulatory and environmental changes as well as complying with new requirements from existing customers

  • 20. The Group defines strategic capital expenditure as the expenditure required to facilitate growth and generate additional returns for the Group. This is generally expansionary expenditure beyond what is necessary to maintain the

Group’s current competitive position

  • 21. Operating cash conversion is defined as Operating Cash Flow (OCF) divided by pre-exceptional EBITDA. Cash conversion is a measure of the Group’s ability to convert trading profits into cash and is an important metric in the

Group’s working capital management programme

  • 22. The compound annual growth rate is the annual growth rate over a period of years. It is calculated on the basis that eachyear’s growth is compounded
  • 23. Dividend Payout Ratio is defined as the interim dividend per ordinary share divided by the Adjusted Earnings per Share atthe end of the current reported period. The dividend payout ratio provides an indication of the value

returned to shareholders relative to the Group's total earnings

slide-36
SLIDE 36

Adjusted EPS

Glanbia plc | Half Year 2020 presentation 36

€’m Reported currency Constant currency

Adjusted EPS

HY 2020 HY 2019 HY 2019

Profit attributable to equity holders of the Company 55.3 83.3 85.1 Exceptional Items 14.6 3.5 3.6 Profit attributable to equity holders of the Company - pre-exceptional 69.9 86.8 88.7 Amortisation (net of tax)* 21.8 21.5 22.0 Adjusted net income 91.7 108.3 110.7 Weighted average number of ordinary shares in issue (millions) 295.3 295.2 295.2 Adjusted Earnings Per Share (cent) 31.05 36.69 37.50 Constant currency growth

  • 17.2%

*Amortisation and impairment of intangible assets (excluding software amortisation) net of related tax of €3.7 million (HY 2019: €3.9 million, 2019: €8.1 million)

slide-37
SLIDE 37

Segmental Analysis

Glanbia plc | Half Year 2020 presentation 37

€’m Reported currency Constant currency

Glanbia Performance Nutrition

HY 2020 HY 2019 HY 2019 Growth %

Revenue 532.4 620.1 630.6

  • 15.6%

EBITA 19.6 46.9 47.9

  • 59.1%

EBITA margin 3.7% 7.6% 7.6%

  • 390 bps

€’m Reported currency Constant currency

Glanbia Nutritionals

HY 2020 HY 2019 HY 2019 Growth %

Revenue* 1,304.3 1,138.3 1,165.0 12.0% EBITA 65.4 64.5 66.0

  • 0.9%

EBITA margin 5.0% 5.7% 5.7%

  • 70 bps

*As a result of the adoption of IFRS 15 in 2019, Revenue in Glanbia Nutritionals includes 100% of revenue from the Southwest Cheese joint venture. All comparisons are on a like-for-like basis

slide-38
SLIDE 38

Segmental Analysis

Glanbia plc | Half Year 2020 presentation 38

€'m Reported currency Constant currency

Nutritional Solutions

HY 2020 HY 2019 HY 2019 Growth %

Revenue* 387.9 369.6 376.9 2.9% EBITA 48.1 50.5 51.6

  • 6.8%

EBITA margin 12.4% 13.7% 13.7%

  • 130 bps

€'m Reported currency Constant currency

US Cheese

HY 2020 HY 2019 HY 2019 Growth %

Revenue* 916.4 768.7 788.1 16.3% EBITA 17.3 14.0 14.4 20.1% EBITA margin 1.9% 1.8% 1.8% +10 bps

*As a result of the adoption of IFRS 15 in 2019, Revenue in Glanbia Nutritionals (Nutritional Solutions & US Cheese) includes 100% of revenue from the Southwest Cheese joint venture. All comparisons are on a like-for-like basis

slide-39
SLIDE 39

Segmental Analysis

Glanbia plc | Half Year 2020 presentation 39

€'m Reported currency Constant currency

Revenue

HY 2020 HY 2019 HY 2019 Growth %

Glanbia Performance Nutrition 532.4 620.1 630.6

  • 15.6%

Nutritional Solutions 387.9 369.6 376.9 2.9% US Cheese 916.4 768.7 788.1 16.3% Glanbia Nutritionals* 1,304.3 1,138.3 1,165.0 12.0% Wholly-owned Revenue 1,836.7 1,758.4 1,795.6 2.3%

*As a result of the adoption of IFRS 15 in 2019, Revenue in Glanbia Nutritionals includes 100% of revenue from the Southwest Cheese joint venture. All comparisons are on a like-for-like basis

slide-40
SLIDE 40

Segmental Analysis

Glanbia plc | Half Year 2020 presentation 40

€'m Reported currency Constant currency EBITA HY 2020 HY 2019 HY 2019 Growth %

Glanbia Performance Nutrition 19.6 46.9 47.9

  • 59.1%

Nutritional Solutions 48.1 50.5 51.6

  • 6.8%

US Cheese 17.3 14.0 14.4 20.1% Glanbia Nutritionals 65.4 64.5 66.0

  • 0.9%

Wholly-owned EBITA 85.0 111.4 113.9

  • 25.4%